VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
-2.98%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$251M
AUM Growth
-$19M
(-7%)
Cap. Flow
-$3.64M
Cap. Flow
% of AUM
-1.45%
Top 10 Holdings %
Top 10 Hldgs %
7.1%
Holding
477
New
43
Increased
256
Reduced
137
Closed
41
Top Buys
| 1 |
The Mosaic Company
MOS
|
+$900K |
| 2 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$877K |
| 3 |
Enphase Energy
ENPH
|
+$858K |
| 4 |
Gartner
IT
|
+$732K |
| 5 |
Devon Energy
DVN
|
+$727K |
Top Sells
| 1 |
L3Harris
LHX
|
+$740K |
| 2 |
Cheniere Energy
CQP
|
+$732K |
| 3 |
Agilent Technologies
A
|
+$713K |
| 4 |
Copart
CPRT
|
+$688K |
| 5 |
Equifax
EFX
|
+$678K |
Sector Composition
| 1 | Healthcare | 18.83% |
| 2 | Real Estate | 17.55% |
| 3 | Materials | 12.77% |
| 4 | Financials | 9.88% |
| 5 | Energy | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Weyerhaeuser
WY
$18.7B
| $547K | 0.22% |
19,140
+1,105
| +6% | +$31.6K |
|
202
Tyson Foods
TSN
$19.9B
| $545K | 0.22% |
8,264
+567
| +7% | +$37.4K |
|
203
Edwards Lifesciences
EW
$47.1B
| $541K | 0.22% |
6,548
+559
| +9% | +$46.2K |
|
204
Monolithic Power Systems
MPWR
$41.4B
| $541K | 0.22% |
+1,490
| New | +$541K |
|
205
Fortinet
FTNT
$61.6B
| $540K | 0.22% |
10,984
-741
| -6% | -$36.4K |
|
206
Waters Corp
WAT
$18.4B
| $524K | 0.21% |
+1,944
| New | +$524K |
|
207
Church & Dwight Co
CHD
$23B
| $521K | 0.21% |
7,291
-20
| -0.3% | -$1.43K |
|
|
CCXI
208
DELISTED
ChemoCentryx, Inc.
CCXI
| $520K | 0.21% |
10,074
+144
| +1% | +$7.43K |
|
209
Steris
STE
$24.5B
| $514K | 0.2% |
3,093
+58
| +2% | +$9.64K |
|
|
XFLT
210
XAI Octagon Floating Rate and Alternative Income Trust
XFLT
$423M
| $508K | 0.2% |
85,493
-5,327
| -6% | -$31.7K |
|
|
HZNP
211
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $501K | 0.2% |
+8,094
| New | +$501K |
|
212
Qualcomm
QCOM
$173B
| $493K | 0.2% |
4,360
-1,168
| -21% | -$132K |
|
213
SLR Investment Corp
SLRC
$917M
| $489K | 0.2% |
39,705
-6,907
| -15% | -$85.1K |
|
|
BKCC
214
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $483K | 0.19% |
142,346
-43,994
| -24% | -$149K |
|
|
FCT
215
First Trust Senior Floating Rate Income Fund II
FCT
$261M
| $482K | 0.19% |
48,234
-3,460
| -7% | -$34.6K |
|
216
Advanced Micro Devices
AMD
$246B
| $473K | 0.19% |
7,460
-915
| -11% | -$58K |
|
217
FS KKR Capital
FSK
$5.07B
| $472K | 0.19% |
27,854
-10,611
| -28% | -$180K |
|
218
Axsome Therapeutics
AXSM
$6.45B
| $465K | 0.19% |
10,413
+154
| +2% | +$6.88K |
|
219
PTC Therapeutics
PTCT
$4.52B
| $461K | 0.18% |
9,177
+134
| +1% | +$6.73K |
|
220
NVIDIA
NVDA
$4.1T
| $457K | 0.18% |
37,640
+380
| +1% | +$4.61K |
|
221
Akero Therapeutics
AKRO
$3.57B
| $442K | 0.18% |
12,981
+99
| +0.8% | +$3.37K |
|
222
Goldman Sachs BDC
GSBD
$1.3B
| $437K | 0.17% |
30,245
-6,011
| -17% | -$86.9K |
|
223
TriplePoint Venture Growth BDC
TPVG
$275M
| $437K | 0.17% |
40,228
-4,611
| -10% | -$50.1K |
|
224
MidCap Financial Investment
MFIC
$1.21B
| $422K | 0.17% |
41,248
-22,363
| -35% | -$229K |
|
225
Apellis Pharmaceuticals
APLS
$3.4B
| $414K | 0.17% |
6,056
+86
| +1% | +$5.88K |
|